Iyer, V., Slivicki, R. A., Thomaz, A. C., Crystal, J. D., Mackie, K., & Hohmann, A. G. (2020). The cannabinoid CB(2) receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependence. Eur J Pharmacol.
Chicago Style CitationIyer, Vishakh, Richard A. Slivicki, Ana C. Thomaz, Jonathon D. Crystal, Ken Mackie, i Andrea G. Hohmann. "The Cannabinoid CB(2) Receptor Agonist LY2828360 Synergizes With Morphine to Suppress Neuropathic Nociception and Attenuates Morphine Reward and Physical Dependence." Eur J Pharmacol 2020.
Cita MLAIyer, Vishakh, et al. "The Cannabinoid CB(2) Receptor Agonist LY2828360 Synergizes With Morphine to Suppress Neuropathic Nociception and Attenuates Morphine Reward and Physical Dependence." Eur J Pharmacol 2020.